Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis
Objectives: To correlate audiometry with atherosclerosis. Presbycusis is associated with age and atherosclerosis; a strong correlation might present opportunities to use audiometry to track atherosclerosis disease. Design: The authors tested 87 elderly patients with rheumatoid arthritis (age ran...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2020-07-01
|
| Series: | European Medical Journal Rheumatology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/rheumatology/article/using-audiometry-to-track-atherosclerosis-measuring-a-beneficial-effect-of-methotrexate-in-rheumatoid-arthritis/ |
| _version_ | 1818096205961363456 |
|---|---|
| author | Kylie Greenwald Maria Greenwald JoAnn Ball |
| author_facet | Kylie Greenwald Maria Greenwald JoAnn Ball |
| author_sort | Kylie Greenwald |
| collection | DOAJ |
| description | Objectives: To correlate audiometry with atherosclerosis. Presbycusis is associated with age and atherosclerosis; a strong correlation might present opportunities to use audiometry to track atherosclerosis disease.
Design: The authors tested 87 elderly patients with rheumatoid arthritis (age range: 80–101 years; median: 86 years) with a history of methotrexate use for over 20 years. After 50 years of age, hearing loss begins slowly and by the age of 90, the majority of the general population require hearing aids. In the 87 elderly participants, however, hearing was remarkably preserved.
Results: The observed cohort of 87 individuals showed better hearing than predicted compared to audiometry historically documented in the elderly (p<0.001). The patients tested one to two decades younger than expected on audiometry and 44% of patients qualified for hearing aids instead of the expected 80%, based on age.
Conclusion: The known reduction in atherosclerosis with methotrexate use in rheumatoid arthritis may account for this observed preservation of hearing.1,2 As hearing and atherosclerosis are related, the authors further postulated that routine audiometry may provide a cost-effective screening tool for other populations in future atherosclerosis studies. |
| first_indexed | 2024-12-10T23:00:56Z |
| format | Article |
| id | doaj.art-874578ddcfa54512ba0ffc0281c7380c |
| institution | Directory Open Access Journal |
| issn | 2056-6395 |
| language | English |
| last_indexed | 2024-12-10T23:00:56Z |
| publishDate | 2020-07-01 |
| publisher | European Medical Journal |
| record_format | Article |
| series | European Medical Journal Rheumatology |
| spelling | doaj.art-874578ddcfa54512ba0ffc0281c7380c2022-12-22T01:30:09ZengEuropean Medical JournalEuropean Medical Journal Rheumatology2056-63952020-07-0171110117Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid ArthritisKylie Greenwald0Maria Greenwald1JoAnn Ball2Desert Medical Advances, Palm Desert, California, USADesert Medical Advances, Palm Desert, California, USADesert Medical Advances, Palm Desert, California, USAObjectives: To correlate audiometry with atherosclerosis. Presbycusis is associated with age and atherosclerosis; a strong correlation might present opportunities to use audiometry to track atherosclerosis disease. Design: The authors tested 87 elderly patients with rheumatoid arthritis (age range: 80–101 years; median: 86 years) with a history of methotrexate use for over 20 years. After 50 years of age, hearing loss begins slowly and by the age of 90, the majority of the general population require hearing aids. In the 87 elderly participants, however, hearing was remarkably preserved. Results: The observed cohort of 87 individuals showed better hearing than predicted compared to audiometry historically documented in the elderly (p<0.001). The patients tested one to two decades younger than expected on audiometry and 44% of patients qualified for hearing aids instead of the expected 80%, based on age. Conclusion: The known reduction in atherosclerosis with methotrexate use in rheumatoid arthritis may account for this observed preservation of hearing.1,2 As hearing and atherosclerosis are related, the authors further postulated that routine audiometry may provide a cost-effective screening tool for other populations in future atherosclerosis studies.https://www.emjreviews.com/rheumatology/article/using-audiometry-to-track-atherosclerosis-measuring-a-beneficial-effect-of-methotrexate-in-rheumatoid-arthritis/atherosclerosisaudiometrymethotrexaterheumatoid arthritis |
| spellingShingle | Kylie Greenwald Maria Greenwald JoAnn Ball Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis European Medical Journal Rheumatology atherosclerosis audiometry methotrexate rheumatoid arthritis |
| title | Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis |
| title_full | Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis |
| title_fullStr | Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis |
| title_full_unstemmed | Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis |
| title_short | Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis |
| title_sort | using audiometry to track atherosclerosis measuring a beneficial effect of methotrexate in rheumatoid arthritis |
| topic | atherosclerosis audiometry methotrexate rheumatoid arthritis |
| url | https://www.emjreviews.com/rheumatology/article/using-audiometry-to-track-atherosclerosis-measuring-a-beneficial-effect-of-methotrexate-in-rheumatoid-arthritis/ |
| work_keys_str_mv | AT kyliegreenwald usingaudiometrytotrackatherosclerosismeasuringabeneficialeffectofmethotrexateinrheumatoidarthritis AT mariagreenwald usingaudiometrytotrackatherosclerosismeasuringabeneficialeffectofmethotrexateinrheumatoidarthritis AT joannball usingaudiometrytotrackatherosclerosismeasuringabeneficialeffectofmethotrexateinrheumatoidarthritis |